Search Results 441-450 of 18325 for total bilirubin

1. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Serum bilirubin within normal range (or ≤ 1.5 x upper limit of normal [ULN] if liver metastases are present; or total bilirubin ≤ 3.0 x ULN with direct ...

2. A Study of Vaccine Therapy in Treating Patients With Recurrent Glioblastoma - Mayo Clinic

   Total bilirubin ≤1.5 x upper limit of normal (ULN);; SGOT (AST) ≤3 x ULN;; Creatinine ≤1.5 x ULN. Negative pregnancy test done ≤7 days prior to ...

3. A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment - Mayo Clinic

   Serum chemistry (as determined by local laboratory):. Serum total bilirubin > 3.0 mg/dL;; 50 < AST < 400 IU/L;; ALT < 400 IU/L;; AST/ALT > 1.5. Maddrey's ...

4. Testing The Role Of DNA Released From Tumor Cells Into The Blood In Guiding The Use Of Immunotherapy After Surgical Removal Of The Bladder, Kidney, Ureter, And Urethra For Urothelial Cancer Treatment, MODERN Study - Mayo Clinic

   PRE-REGISTRATION: Total bilirubin =< 1.5 x upper limit of normal (ULN) (except in patients with Gilbert Syndrome, who can have total bilirubin < 3.0 mg/dL).

5. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Bilirubin ≤ 1.5 x ULN (except subjects with Gilbert's Syndrome, who must have a total bilirubin < 3.0 mg/dL and direct bilirubin < 0.5 mg/dL. Ability to ...

6. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

   Serum bilirubin V 1.5 x ULN (≤ 3.0 x ULN if liver metastases are present; total bilirubin ≤ 3.0 x ULN and direct bilirubin within the normal range in patients ...

7. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

   Phase II part 2: For patients with hepatic metastases - no more than 3 hepatic lesions in total ... Total bilirubin ≤ 1.5 x ULN;; Serum transaminases (alanine ...

8. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

   - Total bilirubin < 1.5 x institutional upper limit normal (ULN) - AST/ALT < 2. 5 - 3x ULN (Options for patients with liver dysfunction may be available)

9. A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma - Mayo Clinic

   Must have total serum bilirubin ≤ 3 mg/dl; ≥ 18 years of age; Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 ...

10. A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination with Other Treatments in Subjects with Multiple Myeloma - Mayo Clinic

    Light chain multiple myeloma without measurable disease in serum or urine: serum ... Serum total bilirubin and alkaline phosphatase > 1.5 x ULN;; Subjects with ...